David Arterburn to Gastrectomy
This is a "connection" page, showing publications David Arterburn has written about Gastrectomy.
Connection Strength
2.165
-
The Effect of Bariatric Surgery on Long-term Depression Treatment in Patients With Obesity. Ann Surg. 2022 08 01; 276(2):318-323.
Score: 0.205
-
Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021 12 01; 156(12):1160-1169.
Score: 0.196
-
Comparative Effectiveness of Vertical Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Diabetes Treatment: A Claims-based Cohort Study. Ann Surg. 2021 05 01; 273(5):940-948.
Score: 0.189
-
Five-year Longitudinal Cohort Study of Reinterventions After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Ann Surg. 2021 04 01; 273(4):758-765.
Score: 0.188
-
Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020 09 01; 324(9):879-887.
Score: 0.180
-
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020 05 01; 155(5):e200087.
Score: 0.176
-
Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surg. 2020 03 01; 155(3):194-204.
Score: 0.174
-
Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database. JAMA Netw Open. 2019 12 02; 2(12):e1917603.
Score: 0.171
-
Comparing the Outcomes of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass for Severe Obesity. JAMA. 2018 01 16; 319(3):235-237.
Score: 0.150
-
Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013 Jul-Aug; 7(4):e258-68.
Score: 0.110
-
Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022 10 01; 157(10):897-906.
Score: 0.052
-
Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population. JAMA Netw Open. 2022 09 01; 5(9):e2233843.
Score: 0.052
-
Association of Insurance Coverage With Adoption of Sleeve Gastrectomy vs Gastric Bypass for Patients Undergoing Bariatric Surgery. JAMA Netw Open. 2022 08 01; 5(8):e2225964.
Score: 0.051
-
Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. JAMA Netw Open. 2022 05 02; 5(5):e229661.
Score: 0.051
-
Comparative effectiveness of gastric bypass and sleeve gastrectomy on predicted 10-year risk of cardiovascular disease 5 years after surgery. Surg Obes Relat Dis. 2022 06; 18(6):716-726.
Score: 0.050
-
Interventions and Operations after Bariatric Surgery in a Health Plan Research Network Cohort from the PCORnet, the National Patient-Centered Clinical Research Network. Obes Surg. 2021 08; 31(8):3531-3540.
Score: 0.047
-
Concurrent hiatal hernia repair and bariatric surgery: outcomes after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2021 Jan; 17(1):72-80.
Score: 0.045
-
Long-term opioid use after bariatric surgery. Surg Obes Relat Dis. 2020 Aug; 16(8):1100-1110.
Score: 0.044
-
Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg. 2016 11 01; 151(11):1046-1055.
Score: 0.035